In this two-page edition of Pharmacy Pearls, you will find updates on continuous glucose monitors (CGMs), including differences between the available devices, insurance coverage information, and patient counseling information. We…
In this edition of Pharmacy Pearls, we have compiled some of the key updates from the 2023 American Diabetes Association Standards of Medical Care in Diabetes. One major highlight is…
In this edition of Pharmacy Pearls, you will find a review of the indications for the SGLT-2 inhibitors. This class of medications initially marketed for type 2 diabetes, has now…
In this edition of Pharmacy Pearls, you will find information about the new medication approved for treating type 2 diabetes in adults, tirzepatide (Mounjaro®). It has a novel mechanism of…
In this edition of Pharmacy Pearls, you will find a few key updates from the 2022 American Diabetes Association Standards of Medical Care in Diabetes. Most notably, metformin (while still…
This edition of Pharmacy Pearls reviews some of the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss, including a review of the newest approved…
This edition of Pharmacy Pearls provides an overview of continuous glucose monitoring systems (CGMs), including: patient populations where the use of CGMs may be beneficial based on recommendations in the…
This edition of Pharmacy Pearls reviews the available long-acting insulins on the market and how to convert between them if insurance coverage or patient preference necessitates switching products. As always,…
This edition of Pharmacy Pearls compares the CV outcome study characteristics and results for both the glucagon-like peptide-1 receptor agonist (GLP-1 RA) and sodium glucose cotransporter 2 (SGLT2) inhibitor classes…
